Author: Miguel Oliveira
-
HLTH Europe 2026 – Amsterdam
Is Diagnostics at the Table? HLTH Europe 2026 offers a useful test of diagnostics’ position within the wider transformation of healthcare. The programme is built around many of the questions currently shaping care delivery: artificial intelligence, interoperability, health-data infrastructure, prevention, evidence generation, clinical implementation, and the redesign of patient pathways. Diagnostics is indispensable to each…
-
MedTech Forum 2026 – Stockholm
When Competitiveness Became the Main Signal The MedTech Forum 2026 produced an unusually clear signal. Across three days of sessions and professional exchanges in Stockholm, discussions repeatedly returned to a concern extending beyond regulation alone: whether Europe can maintain the industrial conditions required to convert medical innovation into sustainable scale. MDR and IVDR remained important,…
-
IVD Industry Monograph No. 3
Beyond Market Access – Foundations for Sustaining Europe’s IVD Leadership Europe’s diagnostics industry shows visible continuity but declining structural durability. IVD’s share of healthcare expenditure fell from 0.80% in 2009 to 0.60% in 2023. Real growth is weak. Capital duration is stressed. Regulatory and evidence obligations fall disproportionately on smaller suppliers. Five structural gaps—competitiveness, fixed-burden…
-
ESCMID Global 2026 Munich
When Diagnostics Became Infrastructure ESCMID Global 2026 offered a clear view of how diagnostics is changing within infectious-disease management. Across five days in Munich, clinicians, microbiologists, researchers, public-health specialists, and industry participants gathered around an extensive scientific programme covering antimicrobial resistance, antibiotics, vaccines, surveillance, emerging pathogens, infection prevention, clinical microbiology, and the broader management of…
-
IVD Industry Monograph No. 2
Earning Position: How Evidence Becomes Authority Diagnostics fail not analytically but through Evidence Escape: evidence does not automatically become clinical authority. Seven evidence domains govern adoption—analytical, clinical, regulatory, economic, operational. Strength in one domain cannot compensate for weakness elsewhere. The binding-constraint principle identifies the missing domain preventing adoption. Connected laboratories are evidence-generating assets, not merely…
-
Analytica 2026 Munich
Where Analytical Power Meets the Diagnostics Moat analytica 2026 offered a useful vantage point from which to observe technologies before they become diagnostics. Across the exhibition halls in Munich, analytical capability was visible in many forms: proteomics platforms, mass spectrometry in multiple configurations, sequencing automation, flexible pre-analytical robotics, increasingly sophisticated assay workflows, and a broad…
-
IVD Industry Monograph No. 1
Crossing from Analytical to Diagnostics: The Difficulty is the Moat Most analytical technologies never reach clinical diagnostics—not due to inadequate performance, but because clinical markets demand structural transformation: from flexibility to constraint, standardization and manufacturer accountability. The crossing requires seven simultaneous conditions across three phases. This structural distance is not a barrier to avoid but…
-
health.tech global summit 2026
When Innovation Became a Partnership Question Healthcare innovation is abundant. Converting it into sustained adoption remains more difficult. That distinction became increasingly visible at health.tech global summit 2026 in Basel. Across a large and energetic gathering of startups, corporates, investors, advisors, institutional actors, and international delegations, innovation appeared in many forms: artificial intelligence, digital platforms,…
-
DxPx Europe 2026
Fast Contacts, Serious Projects, and the Search for the Right Partners DxPx Europe 2026 was my first direct exposure to this particular diagnostics, biotools, precision-medicine, and digital-health partnering environment. It was also a useful reminder that the quality of an industry event is not determined only by the speakers or the formal agenda. It depends…
-
The Book – INSIGHT 6
Health Intelligence Will Not Remove Constraint. It Will Densify It. The next frontier is not more data. It is the ability to sustain trustworthy meaning across systems. Why does this matter now? Artificial intelligence is accelerating expectations across healthcare. Diagnostics sits close to the centre of that discussion because it already generates structured biological information…